EWEarnings Release财报快讯SEC sourceSEC 来源Source link原始来源August 5, 20262026/8/5by InvestLog AIInvestLog AI 整理

Edwards Lifesciences Corporation (EW) 2026 Q2 financial resultsEdwards Lifesciences Corporation (EW) 2026 Q2 财报发布

Key Results

Edwards Lifesciences Corporation reported revenue $1.7B, net income $242M.

Period: 2026 Q2

Revenue: $1.7B

Gross profit: $1.3B; Gross margin: 77.5%

Net income: $242M; GAAP diluted EPS: $0.42

Operating cash flow: $696M; Capex: $132M; Free cash flow: $564M

Cash: $2.9B; Total debt: $704M; Net cash: $2.2B

Official release: 10-Q

Edwards Lifesciences Corporation 公布2026 Q2财报：营收 $1.7B，净利润 $242M。

期间：2026 Q2

营收：$1.7B

毛利润：$1.3B；毛利率：77.5%

净利润：$242M；GAAP 稀释 EPS：$0.42

经营现金流：$696M；资本开支：$132M；自由现金流：$564M

现金：$2.9B；总债务：$704M；净现金：$2.2B

For information only. Not investment advice.内容仅供参考，不构成投资建议。